Tune raises $175M for hepatitis B medicine, epigenetic research
BioPharma Drive: Drug Pricing
JANUARY 12, 2025
The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat chronic hepatitis B infections.
Let's personalize your content